Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
- 1 December 1996
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 348 (9041) , 1535-1541
- https://doi.org/10.1016/s0140-6736(96)07088-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Comparison of methods for defining prevalent vertebral deformities: The study of osteoporotic fracturesJournal of Bone and Mineral Research, 1995
- Femoral bone loss progresses with age: A longitudinal study in women over age 65Journal of Bone and Mineral Research, 1994
- Risk of hip fracture in women with vertebral fractureJournal of Bone and Mineral Research, 1994
- Vertebral fracture assessment using a semiquantitative techniqueJournal of Bone and Mineral Research, 1993
- Hip fractures in the elderly: A world-wide projectionOsteoporosis International, 1992
- Treatment of Postmenopausal Osteoporosis with Calcitriol or CalciumNew England Journal of Medicine, 1992
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry.BMJ, 1987
- Effect of the Fluoride/Calcium Regimen on Vertebral Fracture Occurrence in Postmenopausal OsteoporosisNew England Journal of Medicine, 1982